USPTO serial 79196143
ALG PHARMA
Reviewed by CopyMark Law Group
Reg. 5445428Status 709
- Filing date
- Status date
- Registration date
- Apr 17, 2018
- Examiner
- LEIPZIG, MARC J
- Law office
- TMO LAW OFFICE 115
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ALG PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeannine A Rittenhouse
Jeannine A Rittenhouse IpHorgan Ltd.195 Arlington Heights RoadSuite 125Buffalo Grove, IL 60089Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Seaweeds for use as fertilizers; algae for use as fertilizers; calcium-based algae nutrient supplements for use in aquariums; algae extracts for the manufacture of pharmaceutical products, namely, in the nature of dietary food supplements, pharmaceuticals and veterinary products; nutritive additive to enhance the biological activity of plants for purposes of fertilization and bioremediation of pollutants; seaweed and seaweed extracts for preventing infections in plants; chemical preparations of trace elements for preventing infections in plants; plant growth regulating preparations; cultures of microorganisms other than for medical and veterinary use; biological tissue cultures other than for medical or veterinary [ purposes ] * use * ; biological preparations for use in cell cultures other than for medical or veterinary use; diagnostic preparations other than for medical or veterinary [ purposes ] * use * ; preparations of microorganisms other than for medical or veterinary use; chemical reagents other than for medical or veterinary use; chemical preparations for scientific use other than for medical or veterinary use; chemical products for analyses in laboratories other than for medical or veterinary use * ; all the aforesaid goods being algae-based and none of these goods intended for use in connection with the treatment of allergies, asthma, rhinitis, anaphylactic reactions and other respiratory diseases * | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical products, namely, pharmaceutical preparations for the prevention and treatment of cancers, of disorder of the central nervous system, of digestive disorder, of respiratory disorder, of urinary and sexual disorder, of immunity system disorder, of bone and joint disorder, of mucosal and skin disorder, of vascular and hemostasis disorder, and of infectious disease; sanitary preparations for medical purposes; dietetic foods adapted for medical purposes for human use, namely, cereals and cereal-based foods made with grains and flours in the nature of breads, pastas, tortillas, sweet biscuits, savoury biscuits, cakes, doughs, crispbread and breakfast cereals, vegetables and vegetable-based foods made with texturized vegetable protein, leaf proteins, soya, fungi, vegetable juices, algae, fruit juices, nuts and seeds and nut-based foods, fish, mollusks and their eggs, crustaceans and their eggs, processed, dried, salted, smoked and canned fish, meat and meat-based foods in the nature of processed meat, eggs, milk and milk-based foods and beverages in the nature of creams, yoghurts, cheeses, milk-based cream desserts and ice creams, sugars and syrups being confectionery, desserts, jams jellies, preserves, beverages in the nature of teas, coffees, cordials, soft drinks, fruit flavoured drinks, herbs, spices; food for babies; food supplements for humans; disinfectants; preparations for destroying vermin; fungicides, [ herbicides, ] parasiticides * ; all the aforesaid goods pertaining to the pharmaceutical sector * ; plant extracts for pharmaceutical use; medicinal plant extracts; diagnostic agents for medical purposes; living cells for medical use; stem cells for medical use; enzymes for medical use; bacteriological preparations for medical use; plant preparations being plan extracts for medical use; bacteriological preparations for medical use; biochemical preparations for medical purposes, namely, for the prevention and treatment of cancers, of disorder of the central nervous system, of digestive disorder, of respiratory disorder, of urinary and sexual disorder, of immunity system disorder, of bone and joint disorder, of mucosal and skin disorder, of vascular and hemostasis disorder, and of infectious disease; biological preparations for medical use, namely, for the for the prevention and treatment of cancers, of disorder of the central nervous system, of digestive disorder, of respiratory disorders, of urinary and sexual disorders, of immunity system disorder, of bone and joint disorder, of mucosal and skin disorder, of vascular and hemostasis disorder, and of infectious disease; biotechnological preparations for medical use, namely, for the for the prevention and treatment of cancers, of disorder of the central nervous system, of digestive disorder, of respiratory disorder, of urinary and sexual disorder, of immunity system disorder, of bone and joint disorder, of mucosal and skin disorder, of vascular and hemostasis disorder, and of infectious disease; alginates for pharmaceutical use; iodine for pharmaceutical use * ; all the aforesaid goods being algae-based and none of these goods intended for use in connection with the treatment of allergies, asthma, rhinitis, anaphylactic reactions and other respiratory diseases * | SECTION 71 - CANCELLED | — |
| 042 | Chemical analysis ; scientific analyses, namely, scientific research and scientific laboratory services ; engineering services in the fields of science and technology provided by engineers; scientific and technical research in the fields of human health, human nutrition, animal welfare, animal health, animal nutrition, horticulture and agriculture, algae-based products for food industry and human health; medical research; development of pharmaceutical preparations and medicines; research in the field of pharmaceuticals; research and development in the field of pharmaceuticals; conducting clinical trials for pharmaceutical products; research and development of new products for others in the field of pharmaceuticals; scientific research and development; research and development of vaccines and medicines; medical research laboratory services; conducting scientific feasibility studies * ; all the aforesaid services in connection with the study of algae and none of these services intended for use in connection with the treatment of allergies, asthma, rhinitis, anaphylactic reactions and other respiratory diseases * | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by AMADEITE
- Other trademarks owned by AMADEITE
- Other trademarks owned by AMADEITE
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ALG PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 25, 2025 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 6, 2025 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Dec 6, 2025 | INPC | INVALIDATION PROCESSED | — |
| Jul 1, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 1, 2024 | C71T | CANCELLED SECTION 71 | — |
| Apr 17, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 25, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 25, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 14, 2021 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Apr 19, 2021 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Sep 21, 2018 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Aug 31, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 17, 2018 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Aug 4, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 4, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 17, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 17, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 30, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 30, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 26, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 10, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 10, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 10, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 21, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 21, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 21, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 21, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 21, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 6, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 6, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 6, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 8, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 7, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 7, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 24, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 7, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 7, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 24, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 23, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 22, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 18, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 18, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 17, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |